Victory Capital Management Inc Immunic, Inc. Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020
SELL
$5.67 - $15.86 $7,949 - $22,235
-1,402 Closed
0 $0
Q1 2020

May 04, 2020
SELL
$4.22 - $9.8 $586 - $1,362
-139 Reduced 9.02%
1,402 $8,000
Q4 2019

Feb 04, 2020
SELL
$6.4 - $10.23 $1,196 - $1,913
-187 Reduced 10.82%
1,541 $13,000
Q3 2019

Nov 12, 2019
BUY
$10.0 - $17.01 $17,280 - $29,393
1,728 New
1,728 $17,000

Others Institutions Holding IMUX

# of Institutions
71
Shares Held
56.3M
Call Options Held
100
Put Options Held
350K
View Full List

About IMMUNIC, INC.

IMUX Quotes by TradingView
  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $29M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email